Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Security class unavailable · CUSIP: 359616109
Event date: 2021-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,785,714
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-009633
- Form type
- SC 13G
- Filer
- Fulcrum Therapeutics, Inc.
- CIK
- CIK 1680581
- Filed
- Sep 27, 2021
- Reporting period
- Aug 16, 2021
- Description
- Schedule 13G beneficial ownership